Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications.

Literature DB >> 6111662

Slow hydroxylation of nortriptyline and concomitant poor debrisoquine hydroxylation: clinical implications.

L Bertilsson, B Mellström, F Sjökvist, B Mårtenson, M Asberg.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1981 PMID： 6111662 DOI： 10.1016/s0140-6736(81)92894-4

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

25 in total

Review 1. Molecular genetics of CYP2D6: clinical relevance with focus on psychotropic drugs.

Authors: Leif Bertilsson; Marja-Liisa Dahl; Per Dalén; Ayman Al-Shurbaji
Journal: Br J Clin Pharmacol Date: 2002-02 Impact factor: 4.335

Review 2. Inborn 'errors' of drug metabolism. Pharmacokinetic and clinical implications.

Authors: M S Lennard; G T Tucker; H F Woods
Journal: Clin Pharmacokinet Date: 1990-10 Impact factor: 6.447

Review 3. Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors: R T Coutts; L J Urichuk
Journal: Cell Mol Neurobiol Date: 1999-06 Impact factor: 5.046

Review 4. Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors: Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal: Drug Saf Date: 2006 Impact factor: 5.606

5. Relationship between plasma desipramine levels, CYP2D6 phenotype and clinical response to desipramine: a prospective study.

Authors: E Spina; C Gitto; A Avenoso; G M Campo; A P Caputi; E Perucca
Journal: Eur J Clin Pharmacol Date: 1997 Impact factor: 2.953

Review 6. Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

Authors: J K Hicks; J J Swen; C F Thorn; K Sangkuhl; E D Kharasch; V L Ellingrod; T C Skaar; D J Müller; A Gaedigk; J C Stingl
Journal: Clin Pharmacol Ther Date: 2013-01-16 Impact factor: 6.875

7. Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervals.

Authors: E L Carey; H J Duff; D M Roden; R K Primm; G R Wilkinson; T Wang; J A Oates; R L Woosley
Journal: J Clin Invest Date: 1984-02 Impact factor: 14.808